Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × tremelimumab × Clear all

NCT06680739 2026-06-01

SERPENTINE

Phase 2 Recruiting

GastrointestinalGynecologic

Colorectal Neoplasms, Endometrial Neoplasms

NCT03015129 2024-02-06

A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer

Phase 2 Completed

80 enrolled 9 charts

Recurrence, Endometrial Neoplasms